Vertex Pharmaceuticals

Results: 56



#Item
21Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]Media Alert

Vertex Pharmaceuticals (Australia) Pty Ltd Level 32, 101 Miller Street North Sydney NSW[removed]Media Alert

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2014-11-30 16:49:26
22Annals of medicine  open channels Do new cystic-fibrosis therapies hold the key to treating other genetic disorders? by Jerome Groopman

Annals of medicine open channels Do new cystic-fibrosis therapies hold the key to treating other genetic disorders? by Jerome Groopman

Add to Reading List

Source URL: jeromegroopman.com

Language: English - Date: 2011-09-11 21:50:58
23THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014

THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2014-10-25 23:32:46
24Vertex’s response to the Public Consultation on the Postmarket Review of the Life Saving Drugs Programme Executive Summary In this submission, we set out Vertex’s response to the Post-Market Review of the Life Saving

Vertex’s response to the Public Consultation on the Postmarket Review of the Life Saving Drugs Programme Executive Summary In this submission, we set out Vertex’s response to the Post-Market Review of the Life Saving

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-04 00:09:47
25PharmaSUG2011 - Paper TU02  New Tips and Tricks for Creating a Harmonized, Report-Friendly SDTM and ADaM Lab Data for a Clinical Study Report Xiangchen (Bob) Cui, Vertex Pharmaceuticals, Cambridge, MA Min Chen, Vertex Ph

PharmaSUG2011 - Paper TU02 New Tips and Tricks for Creating a Harmonized, Report-Friendly SDTM and ADaM Lab Data for a Clinical Study Report Xiangchen (Bob) Cui, Vertex Pharmaceuticals, Cambridge, MA Min Chen, Vertex Ph

Add to Reading List

Source URL: www.pharmasug.org

Language: English - Date: 2011-05-06 10:04:19
26Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease MAY 2009 Commissioned by Vertex Pharmaceuticals Incorporated

Consequences of Hepatitis C Virus (HCV): Costs of a Baby Boomer Epidemic of Liver Disease MAY 2009 Commissioned by Vertex Pharmaceuticals Incorporated

Add to Reading List

Source URL: publications.milliman.com

Language: English - Date: 2010-05-17 15:12:38
27HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALYDECO safely and effectively. See full prescribing information for KALYDECO.  -------------------------------CONT

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KALYDECO safely and effectively. See full prescribing information for KALYDECO. -------------------------------CONT

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-01-09 16:45:07
28MedDRA User Group Meeting – Amsterdam, Netherlands Date: 7 March 2013 Morning Agenda: 9:00 - 9:30  Introduction and Welcome

MedDRA User Group Meeting – Amsterdam, Netherlands Date: 7 March 2013 Morning Agenda: 9:00 - 9:30 Introduction and Welcome

Add to Reading List

Source URL: www.meddra.org

Language: English - Date: 2013-04-01 14:52:03
29FOOD AND DRUG ADMINISTRATION

FOOD AND DRUG ADMINISTRATION

Add to Reading List

Source URL: www.fda.gov

Language: English
30CI-1  KALYDECO® (Ivacaftor) Treatment for Cystic Fibrosis Vertex Pharmaceuticals Incorporated Pulmonary and Allergy Drugs

CI-1 KALYDECO® (Ivacaftor) Treatment for Cystic Fibrosis Vertex Pharmaceuticals Incorporated Pulmonary and Allergy Drugs

Add to Reading List

Source URL: www.fda.gov

Language: English